Marshall Wace’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.8M | Sell |
376,242
-158,861
| -30% | -$10M | 0.03% | 472 |
|
2025
Q1 | $28.3M | Sell |
535,103
-157,700
| -23% | -$8.35M | 0.04% | 391 |
|
2024
Q4 | $38.8M | Buy |
692,803
+286,188
| +70% | +$16M | 0.05% | 320 |
|
2024
Q3 | $21.3M | Buy |
406,615
+299,806
| +281% | +$15.7M | 0.03% | 446 |
|
2024
Q2 | $4.39M | Buy |
106,809
+87,059
| +441% | +$3.57M | 0.01% | 952 |
|
2024
Q1 | $856K | Buy |
+19,750
| New | +$856K | ﹤0.01% | 1498 |
|
2023
Q4 | – | Sell |
-34,494
| Closed | -$791K | – | 2234 |
|
2023
Q3 | $791K | Sell |
34,494
-1,877
| -5% | -$43K | ﹤0.01% | 1325 |
|
2023
Q2 | $600K | Sell |
36,371
-57,475
| -61% | -$948K | ﹤0.01% | 1529 |
|
2023
Q1 | $1.67M | Buy |
93,846
+72,563
| +341% | +$1.29M | ﹤0.01% | 1228 |
|
2022
Q4 | $620K | Buy |
+21,283
| New | +$620K | ﹤0.01% | 1749 |
|
2021
Q2 | – | Sell |
-178,757
| Closed | -$3.8M | – | 2484 |
|
2021
Q1 | $3.8M | Buy |
178,757
+159,599
| +833% | +$3.39M | 0.02% | 890 |
|
2020
Q4 | $570K | Sell |
19,158
-9,034
| -32% | -$269K | ﹤0.01% | 1284 |
|
2020
Q3 | $611K | Buy |
28,192
+17,935
| +175% | +$389K | ﹤0.01% | 1141 |
|
2020
Q2 | $229K | Buy |
+10,257
| New | +$229K | ﹤0.01% | 1358 |
|
2019
Q4 | – | Sell |
-2,298
| Closed | -$50K | – | 1957 |
|
2019
Q3 | $50K | Buy |
+2,298
| New | +$50K | ﹤0.01% | 1447 |
|
2019
Q2 | – | Sell |
-14,715
| Closed | -$403K | – | 1730 |
|
2019
Q1 | $403K | Buy |
14,715
+12,417
| +540% | +$340K | ﹤0.01% | 1188 |
|
2018
Q4 | $62K | Buy |
+2,298
| New | +$62K | ﹤0.01% | 1422 |
|